Authors: TOLOMEO M DUSONCHET L MELI M GRIMAUDO S DALESSANDRO N PAPOFF G RUBERTI G RAUSA L

Citation: M. Tolomeo et al., THE CD95 CD95 LIGAND SYSTEM IS NOT THE MAJOR EFFECTOR IN ANTICANCER DRUG-MEDIATED APOPTOSIS/, Cell death and differentiation, 5(9), 1998, pp. 735-742

Authors: MELI M TOLOMEO M DALESSANDRO N GRIMAUDO S RUBERTI G PAPOFF G RAUSA L DUSONCHET L

Citation: M. Meli et al., RESISTANCE TO GEMCITABINE (OEM) IN A FAS-LIGAND (FASL)-RESISTANT CELL-LINE IS NOT DEPENDENT ON THE FAS FASL (CD95/CD95L) SYSTEM/, Annals of oncology, 9, 1998, pp. 638-638

Authors: AUGUGLIARO A DUSONCHET L SANSEVERINO ER

Citation: A. Augugliaro et al., SERVICE RESTORATION IN COMPENSATED DISTRIBUTION NETWORKS USING A HYBRID GENETIC ALGORITHM, Electric power systems research, 46(1), 1998, pp. 59-66

Authors: DALESSANDRO N FLUGY A TOLOMEO M DUSONCHET L

Citation: N. Dalessandro et al., THE APOPTOTIC SIGNALING OF TNF-ALPHA IN MULTIDRUG-RESISTANT FRIEND-LEUKEMIA CELLS, Anticancer research, 18(4C), 1998, pp. 3065-3072

Authors: AUGUGLIARO A DUSONCHET L MANGIONE S

Citation: A. Augugliaro et al., AN EFFICIENT GREEDY APPROACH FOR MINIMUM LOSS RECONFIGURATION OF DISTRIBUTION NETWORKS, Electric power systems research, 35(3), 1995, pp. 167-176

Authors: CROSTA L CANDILORO V MELI M TOLOMEO M RAUSA L DUSONCHET L

Citation: L. Crosta et al., LACIDIPINE AND JOSAMYCIN - 2 NEW MULTIDRUG-RESISTANCE MODULATORS, Anticancer research, 14(6B), 1994, pp. 2685-2689